Stingeni, L., R. Ravasio, C. Palladino, S. Di Fino, A. Levi, G. Ronci, and P. Gisondi. “Cost Per Responder of Upadacitinib 30 Mg and Dupilumab 300 Mg in Patients With Moderate-to-Severe Atopic Dermatitis in Italy”. Global and Regional Health Technology Assessment, vol. 12, no. 1, Mar. 2025, pp. 70-79, doi:10.33393/grhta.2025.3458.